THE following companies saw new developments that may affect trading of their securities on Tuesday (Nov 29):

TLW Success’ offer to take Singapore Medical Group (SMG) private has turned unconditional. TLW Success is an investment vehicle owned by top Singapore Medical Group (SMG) executives.

THE following companies saw new developments that may affect trading of their securities on Thursday (Nov 24):

THE closing date for the voluntary conditional general offer to take Singapore Medical Group (SMG) private has been extended from Nov 23 to Dec 5.

FOLLOWING an offer of S$0.37 per share in cash made in September to take Singapore Medical Group (SMG) private, an investment vehicle owned by the top executives of the company have now raised the offer price to S$0.40 per share or one new share in the offeror.

Dr Beng Teck Liang, who is leading a takeover offer of Singapore Medical Group, has raised the offer price to 40 cents from the original 37 cents.The offer, by Beng, SMG’s CEO and other individuals, was first announced on September 13, adding SMG to the list of SGX-listed companies that are being ...

UOB Kay Hian analyst Llelleythan Tan has advised Singapore Medical Group’s (SMG) shareholders to reject the group’s offer.On Sept 13, SMG’s CEO, non-executive chairman and executive director made a conditional general offer of 37 cents per share to the group’s shareholders.The offer is made ...

UOB Kay Hian (UOBKH) is recommending investors of Singapore Medical Group (SMG) reject TLW Success’ current offer and wait for a potentially better privatisation deal, though Lim & Tan Securities has flagged the risk of the deal falling through.

Catalist-listed Singapore Medical Group (SMG) has received a privatisation bid that will value the company at $180.0 million based on the 486.38 million shares in the company’s issued and paid-up capital. The offer is made with a view to delist and privatise the company.On Sept 13, TLW Success (th...

Separate privatisation offers were made for two SGX-listed companies on Sept 13: Singapore Medical Group and Moya Holdings Asia.Tamaris Infrastructure, the controlling shareholder of Moya Holdings Asia, wants to privatise the company with an offer of 9.2 cents per share.Moya Holdings Asia, based in ...

AN investment vehicle owned by the top executives at the Singapore Medical Group (SMG) has launched an offer to take the company private at S$0.37 per share in cash or 1 new share in the offeror.

Lee has also been keeping an eye out for suitable growth opportunities. As of Dec 31 2021, SPCH has spent $2.4 million, or 67.8% of the $3.54 million raised during its IPO, to expand its business operations locally and regionally.Aside from the balance of $1.14 million in IPO funds, SPCH has amassed...

DESPITE disruptions to operations and diminishing medical tourism amid the pandemic, Catalist-listed Singapore Medical Group (SMG) on Tuesday (Feb 22) posted a 78.8 per cent rise in net profit to S$15.6 million for the full year ended Dec 31, 2021.

OPPORTUNITIES abound beyond Singapore's shores, and specialist healthcare provider Singapore Medical Group (SMG) is raring to go.

THE following companies saw new developments that may affect trading of their securities on Friday: